|
⚲
|
| Critical Biologics Corp | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001387704 |
| Sale | 2009-07-24 ($1.6 M Offered, $0.5 M Sold) |
| Fund | |
| Phone | 6175206662 |
| Address | One Mifflin Place Cambridge, 02138 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2026 |
|---|---|
| James Fordyce | |
| Gerald Chan | |
| Thomas Stossel | |
| Ashleigh Palmer | |
| Scott Coleridge |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
GCM Grosvenor Multi-Asset Class Master Fund III, L.P.
✚
|
0.0 | |
|
GC Norman Holdings LLC
✚
|
0.0 | |
|
GC Partners Holdings, LP
✚
|
0.0 | |
|
GCP Executive Partner Fund II LP
✚
|
0.0 | |
|
GCP Fund II CSP Co-Invest Fund LP
✚
|
0.0 | |
|
GCP HGR Holdings, Inc.
✚
|
0.0 | |
|
GCP Securespace Property Partners-A LP
✚
|
0.0 | |
|
GCP Securespace Property Partners-B LP
✚
|
0.0 | |
|
GCP Securespace Property Partners LP
✚
|
0.0 | |
|
GC Advisors Holdings SG PTE Ltd
✚
|
0.0 |